跳至主要内容
临床试验/NCT04349046
NCT04349046进行中(未招募)不适用

Exception Cementless Femoral Stem in Total Hip Arthroplasty. A Multicenter, Retrospective and Prospective, Non-controlled Post Market Clinical Follow-up Study (Implants and Instrumentation)

Zimmer Biomet6 个研究点 分布在 2 个国家目标入组 332 人开始时间: 2021年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Zimmer Biomet
入组人数
332
试验地点
6
主要终点
Implant survival based on removal or intended removal of the device and determined using the Kaplan-Meier method

研究概览

简要总结

This study is a multicenter, retrospective and prospective, non-controlled, non-randomized post market clinical follow-up study. The objectives of this study are to confirm the long-term safety, performance and clinical benefits the Exception Cementless femoral stem (standard and varized) when used in primary total hip arthroplasty.

详细描述

Six surgeons have prospectively collected clinical data for patients operated consecutively between January 2008 and September 2012. The patients have been operated based on the indications and contraindications listed in the Instructions For Use (IFUs) of the implant.

This study is an extension of the surgeons' data collection as an attempt from Zimmer-Biomet to fulfill its post-market surveillance obligations by recovering clinical data retrospectively and prospectively.

Study Procedure Flowchart - retrospective data collection: most patients had clinical follow-ups at pre-op, operative, immediate post-op, 3 Months, 1 year, 2, 3, 5, 7 years post-surgery during which their surgeons collected clinical data. This data will therefore only be collected by Zimmer-Biomet after the patients specifically consent to it.

Study Procedure Flowchart - prospective data collection: The informed consent signed by the patient for this study also allow Zimmer Biomet to collect the data of the standard clinical follow-up that will be conducted by the investigators at least 10 years post-surgery.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Implant survival based on removal or intended removal of the device and determined using the Kaplan-Meier method

时间窗: 10 years post-surgery

次要结局

  • Safety based on eventual complications occurred including dislocations and revisions/removals(10 years post-surgery])
  • Subject quality-of-life determined by the EQ-5D (EuroQoI) score(10 years post-surgery)
  • Pain and functional performance based on the Harris Hip Score(10 years post-surgery)
  • X-rays evaluated for radiolucencies, osteolysis, hypertrophy, subsidence, heterotopic ossification, etc(10 years post-surgery)

研究者

发起方
Zimmer Biomet
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Exception Cementless Hip Stem | 临床试验